green tick

GSK to cut 90 jobs

0 comments Read Later

GlaxoSmithKline (GSK) announced a change to the business focus and organisational structure of its pharmaceutical division, based in Melbourne, yesterday.

These changes will result in the reduction of about 90 positions from the pharmaceutical business, but will not impact manufacturing.

Geoff McDonald, GSK’s general manager pharmaceuticals said the job cuts came as a result of difficult conditions in the Australian market.

“Funding for medicines is currently very challenging in Australia,” he said.

“We have changed our business strategy to ensure that patients are able to access new treatment options as they emerge from our global pipeline which has seen exceptional progress this year.”

GSK in Australia consists of two main divisions (Pharmaceuticals and Consumer Healthcare) and four manufacturing facilities.


 

 Subscribe to our Newsletter


 Breaking news and special features
 A daily must-read for pharmacists
 Delivered to your inbox
By filling in your email address and clicking submit with this option selected, you agree to receive email communications from us relevant to the healthcare industry. You always have the option of unsubscribing later via an unsubscribe link or your subscriptions management page. View our privacy policy here.

Your profile is
0% complete


 
 

Pharmacy News on Twitter

­

My list
  •  
Read Later